Creative Touch Permanent Makeup and Aesthetics

A low-carbohydrate diet (LCD) restricts total carbohydrate intake to reduce postprandial glucose and insulin excursions. It is not a single protocol – definitions range from moderate restriction (100–130g/day) to very low-carbohydrate or ketogenic levels (below 50g/day) – but the mechanisms relevant to skin health are active across the range and scale with the degree of restriction. The skin-relevant case for carbohydrate reduction rests on two well-evidenced mechanisms – glycation and insulin resistance – rather than on any prescriptive dietary ideology. It is relevant to the aesthetics context not as a lifestyle recommendation but as a mechanistic explanation for why metabolic health and skin quality are not independent variables.

Glycation and AGE Formation

Glucose and fructose react non-enzymatically with free amino groups on proteins in a process called glycation – the Maillard reaction in biological tissue. The early glycation products undergo further irreversible reactions to form advanced glycation end products (AGEs), stable cross-links between adjacent protein chains. In the dermis, this cross-linking affects collagen and elastin directly: two glycated collagen fibrils bound by an AGE cross-link are both rendered resistant to normal enzymatic turnover, accelerating the accumulation of stiff, disorganised matrix that characterises intrinsically aged and photodamaged skin. ^[2]

The rate of AGE formation is not fixed – it accelerates proportionally with ambient glucose concentration. Chronic hyperglycaemia, postprandial glucose spikes, and insulin resistance (which prolongs glucose elevation following meals) all increase the glycation burden in dermal tissue. Ultraviolet light independently accelerates cutaneous glycation, creating an additive pathway in clients with both dietary and photodamage histories. skintherapyletter.com/aging-skin/glycation/ Reducing dietary carbohydrate load lowers postprandial glucose amplitude and duration, directly reducing the glycation rate in dermal collagen – a mechanism that is particularly relevant to any treatment aimed at collagen remodelling or regeneration, where the newly synthesised collagen is entering a chemical environment that will either preserve or progressively damage it.

AGEs also activate receptor-mediated signalling through RAGE (Receptor for Advanced Glycation End-products), triggering NF-κB-driven inflammatory cascades and the upregulation of matrix metalloproteinases (MMPs) – the same enzymes responsible for pathological collagen degradation in ageing and inflammatory skin disease. ^[1] The RAGE pathway therefore provides a second downstream mechanism by which sustained glycaemic burden degrades skin architecture, independent of the direct structural cross-linking effect.

Insulin Resistance and Acne

The association between insulin resistance and acne vulgaris is one of the more robustly documented metabolic-dermatological relationships in the recent literature. A 2023 cross-sectional study found that 67–81% of acne patients demonstrated insulin resistance by C- peptide and triglyceride-glucose (TyG) index, with a strong positive correlation between IR severity and acne severity. ^[5] A matched cohort study excluding confounders of age and BMI confirmed mean HOMA-IR was significantly elevated in acne patients (3.40) versus controls (2.34), supporting an independent metabolic contribution rather than an effect mediated purely by obesity. ^[4]

The mechanistic pathway from insulin resistance to acne operates primarily through IGF-1 and androgen signalling: elevated circulating insulin stimulates hepatic IGF-1 production and suppresses IGFBP-3, increasing bioavailable IGF-1; IGF-1 then drives sebaceous gland hyperplasia, sebum production, and follicular keratinocyte proliferation – the three upstream drivers of comedogenesis. Hyperinsulinaemia also reduces sex hormone binding globulin (SHBG), increasing free androgens and amplifying the sebogenic signal. ^[7] Carbohydrate restriction lowers the insulin response at each meal, reduces chronic hyperinsulinaemia, and over time improves insulin sensitivity – addressing the upstream metabolic driver rather than the downstream sebaceous consequence.

Diabetes Remission Evidence

The strongest clinical evidence for carbohydrate restriction as a metabolic intervention comes from the diabetes remission literature. A 2021 systematic review and meta-analysis of 23 randomised trials found that low-carbohydrate diets achieved diabetes remission (HbA1c below 6.5%) in 57% of participants at six months, compared to 31% on control diets – a risk difference of 0.32 (95% CI 0.17–0.47). ^[3] The DiRECT trial specifically demonstrated that dietary-induced weight loss and carbohydrate reduction in a primary care setting achieved remission in 46% of participants at one year and 36% at two years, with a five-year extension showing that 26% of those in remission at year two remained in remission at year five. ^[6]

For the aesthetics context, these figures are relevant not because they define a treatment goal but because they establish that the metabolic pathology most directly upstream of glycation and the insulin–IGF-1–sebum axis is clinically modifiable through diet – and that the modification is durable in a meaningful proportion of patients. Clients presenting with persistent adult acne, early skin laxity, or slow collagen treatment response who are also metabolically dysregulated are presenting with a modifiable upstream driver, and the dermatological consequences are unlikely to be fully addressable by topical or procedural means while that driver remains active.